Amgen's most recent trend suggests a bullish bias. One trading opportunity on Amgen is a Bull Put Spread using a strike $160.00 short put and a strike $155.00 long put offers a potential 22.25% return on risk over the next 26 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $160.00 by expiration. The full premium credit of $0.91 would be kept by the premium seller. The risk of $4.09 would be incurred if the stock dropped below the $155.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Amgen is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Amgen is bullish.
The RSI indicator is at 60.63 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
Astellas announces termination of Amgen-sponsored clinical studies of rilotumumab in gastric cancer (pdf 76.0KB)
Tue, 25 Nov 2014 00:13:00 GMT
noodls – Microsoft Word – API_Rilo termination release draft 201425 en Astellas final (2) Astellas announces termination of Amgen-sponsored clinical studies of rilotumumab in gastric cancer Tokyo, November 25, …
After-hours buzz: Amgen, Palo Alto Networks & more
Mon, 24 Nov 2014 21:57:09 GMT
Amgen ends studies of gastric cancer drug
Mon, 24 Nov 2014 18:28:39 GMT
Amgen ends studies of gastric cancer drug
Mon, 24 Nov 2014 18:28:39 GMT
JANA Partners opens a stake in Amgen
Mon, 24 Nov 2014 17:00:48 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook